Boston Scientific Corporation (BSX) is a global medical device company that develops, manufactures, and markets a broad range of minimally invasive medical devices. The company's products are used in interventional cardiology, electrophysiology, endoscopy, urology, neuromodulation, and other specialties. BSX focuses on advancing science for life by providing innovative solutions that improve patient health outcomes across numerous therapeutic areas worldwide.
Q2 FY2026 — expected 2026-09-13
| Type | Subject | Detail | Quarter |
|---|---|---|---|
| topic_mention | BSX | discussed Artificial Intelligence | |
| topic_mention | BSX | discussed Blockchain & Crypto | |
| topic_mention | BSX | discussed GPU & Accelerators | |
| topic_mention | BSX | discussed Semiconductor | |
| topic_mention | BSX | discussed Networking | |
| topic_mention | BSX | discussed Robotics | |
| topic_mention | BSX | discussed Supply Chain | |
| topic_mention | BSX | discussed Regulation | |
| topic_mention | BSX | discussed Sovereign & Government | |
| topic_mention | BSX | discussed Enterprise | |
| topic_mention | BSX | discussed Gaming | |
| topic_mention | BSX | discussed Automotive | |
| topic_mention | BSX | discussed Healthcare & Bio | |
| topic_mention | BSX | discussed AI Compute | |
| topic_mention | BSX | discussed Platform & Ecosystem | |
| guidance | BSX | guided expect to Page 76 of 98 generate $3.5 billion | |
| guidance | BSX | guided expect to generate over $13 billion | |
| outlook | BSX | stated we anticipate that range per the last guidance of 18 to 19% | |
| outlook | BSX | stated we expect an d we hope to be able to treat more patients with these lifesaving therapies through that approach | |
| outlook | BSX | stated We expect, over the LRP, we will deliver high single - digit growth |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-17 | 2025-12-31 | 0000885725-26-000010 | EDGAR | 74K words |
| 2025-02-18 | 2024-12-31 | 0000885725-25-000011 | EDGAR | — |
| 2024-02-20 | 2023-12-31 | 0000885725-24-000017 | EDGAR | — |
| 2023-02-23 | 2022-12-31 | 0000885725-23-000008 | EDGAR | — |
| 2022-02-23 | 2021-12-31 | 0000885725-22-000006 | EDGAR | — |
| 2021-02-23 | 2020-12-31 | 0000885725-21-000008 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-08-03 | 2026-06-30 | 0000885725-26-000053 | EDGAR | — |
| 2026-05-01 | 2026-03-31 | 0000885725-26-000033 | EDGAR | — |
| 2025-11-03 | 2025-09-30 | 0000885725-25-000050 | EDGAR | 35K words |
| 2025-08-01 | 2025-06-30 | 0000885725-25-000041 | EDGAR | — |
| 2025-05-01 | 2025-03-31 | 0000885725-25-000026 | EDGAR | — |
| 2024-11-01 | 2024-09-30 | 0000885725-24-000073 | EDGAR | — |
| 2024-08-01 | 2024-06-30 | 0000885725-24-000068 | EDGAR | — |
| 2024-05-01 | 2024-03-31 | 0000885725-24-000046 | EDGAR | — |
| 2023-11-01 | 2023-09-30 | 0000885725-23-000048 | EDGAR | — |
| 2023-08-03 | 2023-06-30 | 0000885725-23-000043 | EDGAR | — |
| 2023-05-04 | 2023-03-31 | 0000885725-23-000026 | EDGAR | — |
| 2022-11-03 | 2022-09-30 | 0000885725-22-000028 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-29 | 0000885725-26-000051 | EDGAR | — |
| 2026-07-27 | 0000885725-26-000049 | EDGAR | — |
| 2026-05-18 | 0000885725-26-000042 | EDGAR | — |
| 2026-05-18 | 0000885725-26-000041 | EDGAR | — |
| 2026-05-05 | 0000885725-26-000036 | EDGAR | — |
| 2026-04-22 | 0000885725-26-000031 | EDGAR | — |
| 2026-03-30 | 0000885725-26-000029 | EDGAR | 1K words |
| 2026-02-26 | 0000885725-26-000017 | EDGAR | — |
| 2026-02-23 | 0000885725-26-000013 | EDGAR | — |
| 2026-02-05 | 0000885725-26-000008 | EDGAR | — |
136 total filings indexed. 108 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| Call Date | Quarter | Title |
|---|---|---|
| — | BSX Earnings Call Transcript | |
| — | Q1 FY2025 | BSX Q1 FY2025 Earnings Call Transcript |
| — | Q2 FY2025 | BSX Q2 FY2025 Earnings Call Transcript |
| — | Q3 FY2025 | BSX Q3 FY2025 Earnings Call Transcript |
| — | Q4 FY2025 | BSX Q4 FY2025 Earnings Call Transcript |
Access full transcripts via API (JSON) — includes speakers, key metrics, competitive mentions, and origin provenance chain.
| CIK | 0000885725 |
| Ticker | BSX |
| Exchange | NYSE |
| SIC | 3841: Surgical & Medical Instruments & Apparatus |
| Incorporated | DE |
| Website | https://www.bostonscientific.com |
| Listed | 1992-05-18 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/BSX (~200 tokens, structured JSON with cryptographic provenance)